Application of the chemokine CXCL12 expression plasmid restores wound healing to near normal in a diabetic mouse model

Journal of Trauma - Injury, Infection and Critical Care

Volumn 69, Issue 2, 2010, Pages 392-398

  Restivo, Terry E ^a   MacE, Kimberly A ^b   Harken, Alden H ^a   Young, David M ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chimeras; CXCL12; Diabetic mice; Endothelial progenitor cells; Plasmid; SDF 1; Stromal derived growth factor 1; Transfection; Wound healing

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DIABETIC WOUND; GENE EXPRESSION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; STEM CELL MOBILIZATION; WOUND; WOUND HEALING;

EID: 77955914591     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181e772b0     Document Type: Article

References (20)

1. Badillo AT, Chung S, Zhang L, Zoltick P, Liechty KW. Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing. J Surg Res. 2007;143:35-42.
2. Hansen SL, Myers CA, Charboneau A, Young DM, Boudreau N. HoxD3 accelerates wound healing in diabetic mice. Am J Pathol. 2003;163: 2421-2431.
3. Fadini GP, Miorin M, Facco M. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449-1457.
4. Loomans CJ, Dao HH, van Zonneveld AJ, Rabelink TJ. Is endothelial progenitor cell dysfunction involved in altered angiogenic processes in patients with hypertension? Curr Hypertens Rep. 2004;6:51-54.
5. Tepper OM, Galiano RD, Capla JM. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106:2781-2786.
6. Sameermahmood Z, Balasubramanyam M, Saravanan T, Rema M. Curcumin modulates SDF-1alpha/CXCR4-induced migration of human retinal endothelial cells (HRECs). Invest Ophthalmol Vis Sci. 2008;49: 3305-3311.
7. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565-568.
8. Hatch HM, Zheng D, Jorgensen ML, Petersen BE. SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells. 2002;4:339-351.
9. Salvucci O, Basik M, Yao L, Bianchi R, Tosato G. Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFNgamma. J Leukoc Biol. 2004;76:217-226.
10. Abu El-Asrar AM, Struyf S, Van Damme J, Geboes K. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol. 2008;92:699-704.
11. Segal MS, Shah R, Afzal A, et al. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes. 2006;55:102-109.
12. Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NOmediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest. 2007;117:1249-1259.
13. Goodson WH III, Hung TK. Studies of wound healing in experimental diabetes mellitus. J Surg Res. 1977;22:221-227.
14. Pituch-Noworolska A, Majka M, Janowska-Wieczorek A, et al. Circulating CXCR4-positive stem/progenitor cells compete for SDF-1-positive niches in bone marrow, muscle and neural tissues: an alternative hypothesis to stem cell plasticity. Folia Histochem Cytobiol. 2003;41:13-21.
15. Avniel S, Arik Z, Maly A, et al. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol. 2006;126:468-476.
16. Mace KA, Yu DH, Paydar KZ, Boudreau N, Young DM. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair. Wound Repair Regen. 2007;15: 636-645.
17. Case J, Mead LE, Bessler WK, et al. Human CD34-AC133- VEGFR-2- cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35:1109-1118.
18. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007;28:299-307.
19. Aicher A, Rentsch M, Sasaki K, et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res. 2007;100:581-589.
20. Liu ZJ, Velazquez OC. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal. 2008;10: 1869-1882.